NCT00098917 2008-01-28Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung CancerNational Cancer Institute (NCI)Phase 1 Terminated15 enrolled